Seoul, South Korea · Founded 2021 · Privately Held (backing)
Operator of an artificial intelligence (AI) based new drug development platform intended to discover high-potency drugs. Aigen Sciences is based in Seoul, South Korea and was founded in 2021. It has raised $12 million.
Last price · $/share
—
Implied valuation
—
Total raised
$12.0M
Last round
—
Team — not yet on record
No current team members for Aigen Sciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aigen Sciences with a free account
·The complete investor list: 11 names
·Watch Aigen Sciences: the Monday email on marks, rounds and moves
